glp 1 urinary tract infection Do GLP‑1 receptor agonists (e.g., semaglutide, liraglutide, dulaglutide, tirzepatide) increase the risk of urinary‑tract infection? Pleitropic effects of GLP-1 or
Description
Treatment Goals: What's Your Target
These injections work by slowing gastric emptying, which means food stays in the stomach longer, making you feel fuller for an extended period
If sleep becomes lighter or less consistent, daytime fatigue may feel more noticeable
Differential effects of oxyntomodulin and GLP-1 on glucose metabolism
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has even more limited reproductive safety data since it is newer than semaglutide
